Head of global research and development at Life Technologies
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO of Brooks Bell Inc.
CEO and Fund Manager, Renaissance Venture Capital Fund
Now in its sixth year, Convergence is a unique opportunity for life sciences executives to meet with investors, understand how policy and industry dynamics are changing, get closer to prospective partners, and learn about new opportunities. Speakers this year hail from the worlds of hospitals and payors, academia and big pharma, venture capital and start-ups including Charlie Baker, CEO, Harvard Pilgrim Health Care; Yvonne Greenstreet, MD, Senior Vice President and Chief of R&D Strategy, GlaxoSmithKline; Jeff Barnes, General Partner, Oxford Bioscience Partners; Elisabet de los Pinos, PhD CEO, Aura Biosciences; and David Altshuler, Director of Medical and Population Genetics, Broad Institute. For more information, please visit www.convergenceforum.com.